<?xml version="1.0" encoding="UTF-8"?>
<p>Pei-Yong Shi (
 <xref ref-type="fig" rid="fig11-2040206618783924">Figure 11</xref>) received his PhD in virology from Georgia State University (1996) and then moved to Yale University for postdoctoral training. He moved to Bristol-Myers Squibb, working on HIV and HCV therapeutics, from 1998 to 2000. He was at Wadsworth Center, New York State Department of Health, to study West Nile virus (2000–2008). At Novartis Institute for Tropical Diseases, he was Dengue Unit Head and Executive Director to lead drug discovery (2008–2015). Currently, Pei-Yong is I.H. Kempner Professor of Human Genetics, University of Texas Medical Branch, Galveston, Texas, USA. Having worked for many years with flaviviruses, he is now developing a vaccine for Zika virus.
</p>
